Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Harding

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of the American Academy of Psychiatry and the Law|September 1, 2023
Regulating Ketamine Use in PsychiatryLisa Harding
Nutrition Research (New York, N.Y.)|November 21, 2016
Maintenance of cytosolic calcium is crucial to extend l-arginine therapeutic benefits during continuous dosingSrinidi Mohan, Lisa Harding
The Primary Care Companion for CNS Disorders|November 27, 2018
An Energy Drink-Induced Manic Episode in an AdolescentSyed Quadri, Lisa Harding, Mathias Lillig
Amino Acids|August 10, 2016
N <sup>w</sup>-hydroxy-L-arginine as a novel ethnic specific indicator of estrogen-negative breast cancerSrinidi Mohan, Nancy Moua, Lisa Harding
Medicine|February 17, 2023
Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorderJoshua Liberman, Jacqueline Pesa, Pinyao Rui, et al.
The Journal of Clinical Psychiatry|May 9, 2024
Barriers to Esketamine Nasal Spray Treatment Among Adults With Treatment-Resistant DepressionKruti Joshi, Joshua N Liberman, Purva Parab, et al.
Drugs - Real World Outcomes|May 10, 2024
Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United StatesLisa Harding, Kruti Joshi, Maryia Zhdanava, et al.
Amino Acids|December 21, 2017
Assessing N <sup>w</sup>-hydroxy-L-arginine applicability as a novel ethnic specific estrogen-negative breast cancer markerSrinidi Mohan, Ian Greenstein, Cathy Ng, et al.
Clinical Therapeutics|January 5, 2025
Health Care Resource Use and Medical Costs Among Patients With Major Depressive Disorder and Acute Suicidal Ideation or Behavior Initiated on Esketamine Nasal Spray or Traditional Treatments in the United StatesLisa Harding, Maryia Zhdanava, Amanda Teeple, et al.
Amino Acids|June 21, 2018
Metabolic relevance for N-hydroxy L-arginine reduction in estrogen-negative breast cancer cellsSrinidi Mohan, Seema Patel, Ian Greenstein, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of the American Academy of Psychiatry and the Law|September 1, 2023
Regulating Ketamine Use in PsychiatryLisa Harding
Nutrition Research (New York, N.Y.)|November 21, 2016
Maintenance of cytosolic calcium is crucial to extend l-arginine therapeutic benefits during continuous dosingSrinidi Mohan, Lisa Harding
The Primary Care Companion for CNS Disorders|November 27, 2018
An Energy Drink-Induced Manic Episode in an AdolescentSyed Quadri, Lisa Harding, Mathias Lillig
Amino Acids|August 10, 2016
N <sup>w</sup>-hydroxy-L-arginine as a novel ethnic specific indicator of estrogen-negative breast cancerSrinidi Mohan, Nancy Moua, Lisa Harding
Medicine|February 17, 2023
Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorderJoshua Liberman, Jacqueline Pesa, Pinyao Rui, et al.
The Journal of Clinical Psychiatry|May 9, 2024
Barriers to Esketamine Nasal Spray Treatment Among Adults With Treatment-Resistant DepressionKruti Joshi, Joshua N Liberman, Purva Parab, et al.
Drugs - Real World Outcomes|May 10, 2024
Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United StatesLisa Harding, Kruti Joshi, Maryia Zhdanava, et al.
Amino Acids|December 21, 2017
Assessing N <sup>w</sup>-hydroxy-L-arginine applicability as a novel ethnic specific estrogen-negative breast cancer markerSrinidi Mohan, Ian Greenstein, Cathy Ng, et al.
Clinical Therapeutics|January 5, 2025
Health Care Resource Use and Medical Costs Among Patients With Major Depressive Disorder and Acute Suicidal Ideation or Behavior Initiated on Esketamine Nasal Spray or Traditional Treatments in the United StatesLisa Harding, Maryia Zhdanava, Amanda Teeple, et al.
Amino Acids|June 21, 2018
Metabolic relevance for N-hydroxy L-arginine reduction in estrogen-negative breast cancer cellsSrinidi Mohan, Seema Patel, Ian Greenstein, et al.
Pageof 2